Androgen deprivation therapy and chemotherapy have been mainstays for prostate cancer treatment. However, as more information becomes known about this disease at the genetic level, other drug classes are being explored which are providing new clinical trial/treatment opportunities for patients.

A description of the classes of drugs being studied for prostate cancer treatment with a selective listing of actively recruiting trials by class: